<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1107927</article-id><article-id pub-id-type="publisher-id">OALibJ-117417</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Prevalence of Opportunist Infections among the Professionals Sex Workers and Their Customers Living with the VIH under ARV in Kinshasa
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Berry</surname><given-names>Ikolango Bongenya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ben</surname><given-names>Ilunga Bulanda</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rama</surname><given-names>Nemwandjare Bukongo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Divine</surname><given-names>Chuga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Huguette</surname><given-names>Tshueka Botomuito</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Yves</surname><given-names>Debels Kabasele</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Erick</surname><given-names>Ntambwe Kamangu</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Faculty of Medicine, Technological University Bel Campus, Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff3"><addr-line>HIV/AIDS Unit, Service of Molecular Biology, Department of Basic Sciences, Faculty of Medicine, University of Kinshasa, Democratic Republic of the Congo</addr-line></aff><aff id="aff2"><addr-line>Research Group “Focus HIV/AIDS”, Kinshasa, Democratic Republic of the Congo</addr-line></aff><pub-date pub-type="epub"><day>09</day><month>05</month><year>2022</year></pub-date><volume>09</volume><issue>05</issue><fpage>1</fpage><lpage>7</lpage><history><date date-type="received"><day>12,</day>	<month>March</month>	<year>2022</year></date><date date-type="rev-recd"><day>24,</day>	<month>May</month>	<year>2022</year>	</date><date date-type="accepted"><day>27,</day>	<month>May</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Context: The Human Immunodeficiency Virus (HIV) is the causal agent of the Acquired Immunodeficiency Syndrome (AIDS). Professional Sex Workers (PSW) are regarded as being at a very high risk of transmission of the VIH and Opportunist Infections. 
  Objective: To determine the prevalence of the opportunistic infections associated the VIH/AIDS on PSW under ARV treatment in Kinshasa. 
  Methods: The present study was carried out at the IST Matonge center in Kinshasa. It was a retrospective study on patients’ files of adult PSW and their clients living with HIV, followed in this medical treatment center from 2006 to 2014. This work included all the files of adult PSW older than 18 years living with HIV followed from 2006 to 2014 in the selected center. Parameters of interest were: age, gender, HIV status, documented opportunistic infections and conditions. The files which did not contain all of the data mentioned above were not included. 
  Results: Eighty-eight (88) files were retained according to the criteria. There were 53 women (60.2%). The most represented age group was the one from 36 to 45 years with 31.8%, followed by that of 26 to 35 years (26.1%), 46 to 55 years (22.7%), 56 to 65 years (10.2%), and that of 18 to 25 years (8.0%). The most diagnosed and recorded opportunistic infection was the Oral Candidiasis with 15.8% of cases; followed by non-specific Sexually Transmitted Infections (STI) with 14.3%, Malaria with 12.1%, Dermatitis with 8.1%, Tuberculosis (TBC) and Shingles with 6.2% respectively. 
  Conclusion: Oral candidiasis (15.8%) was the most common Opportunistic Infection diagnosed among Professional Sex Workers followed at the “IST Matonge Center” in Kinshasa. The profile of OIs among PSWs living with HIV is different from that of general population.
 
</p></abstract><kwd-group><kwd>Opportunistic Infection</kwd><kwd> Professional Sex Worker</kwd><kwd> ARV</kwd><kwd> VIH</kwd><kwd> Kinshasa</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The Human Immunodeficiency Virus (HIV) is the causative agent of the Acquired Immunodeficiency Syndrome (AIDS) [<xref ref-type="bibr" rid="scirp.117417-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>]. This Immunosuppression determines the mortality and morbidity of infected patients by exposing them to frequent and often serious Opportunistic Infections (OI) [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>]. These infections can be of bacterial, viral, parasitic, fungal or other origins [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref3">3</xref>]. Other than immunosuppression, the occurrence of opportunistic infections depends on several other factors including the environment, hygiene and pathogens [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref3">3</xref>].</p><p>In Sub-Saharan Africa, which is the region most affected by HIV infection, the number of studies on HIV and HIV-related infections conducted over the past 25 years is very insufficient compared to those conducted in Europe and other developed countries across the world [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>]. In most countries heavily affected by the AIDS epidemic, Professional Sex Workers (PSW), are considered to be a population at very high risk of HIV transmission [<xref ref-type="bibr" rid="scirp.117417-ref4">4</xref>]. The prevalence of HIV among PSW is higher than in the general population [<xref ref-type="bibr" rid="scirp.117417-ref4">4</xref>]. In sub-Saharan Africa, it was estimated at 19% in 2008, compared to 5.2% among people aged 15 to 49 [<xref ref-type="bibr" rid="scirp.117417-ref5">5</xref>]. Often, it is within this highly exposed population that infection initially spreads before spreading to other segments of the population [<xref ref-type="bibr" rid="scirp.117417-ref6">6</xref>].</p><p>In the Democratic Republic of Congo (DRC), OIs are still a major problem in the care and follow up of People Living with HIV (PLHIV) [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>]. In different centers, this follow up is often limited to the distribution of drugs and treatment of OIs [<xref ref-type="bibr" rid="scirp.117417-ref2">2</xref>]. Some studies have shown that Tuberculosis, Candidiasis, Pneumonia and Malaria are the most common infections in Kinshasa’s population [<xref ref-type="bibr" rid="scirp.117417-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.117417-ref11">11</xref>]. Global care and follow up should take into account OIs whose diagnoses are still incomplete in our environment [<xref ref-type="bibr" rid="scirp.117417-ref11">11</xref>]. The objective of this study was to determine the prevalence of opportunistic infections among HIV infected Professional Sex Workers followed at the STI Matonge Center in Kinshasa.</p></sec><sec id="s2"><title>2. Methods</title><sec id="s2_1"><title>2.1. Study Framework</title><p>The present study was carried out at the IST Matonge center in Kinshasa. It was a retrospective study on patients’ files of adult PSW and their clients living with HIV, followed in this medical treatment center from 2006 to 2014.</p></sec><sec id="s2_2"><title>2.2. Patients</title><p>This work included all the files of adult PSW older than 18 years living with HIV followed from 2006 to 2014 in the selected center. Parameters of interest were: age, gender, HIV status, documented opportunistic infections and conditions. The files which did not contain all of the data mentioned above were not included.</p></sec><sec id="s2_3"><title>2.3. Data Analysis</title><p>Data were collected using previously tested survey forms. They were entered on Windows Excel version 2007.</p></sec><sec id="s2_4"><title>2.4. Operational Definition</title><p>Any infection caused by the immunosuppression, diagnosed by the clinical examination recorded on the HIV patient files, was considered to be an Opportunistic Infection. The infections were confirmed by a series of 3 Immuno-chromatographic Tests according to WHO recommendations. Anyone who has made sexual practice a source of official remuneration has been considered a PSW.</p></sec><sec id="s2_5"><title>2.5. Ethical Consideration</title><p>The study received the authorization from the selected center. The confidentiality of the files of HIV-positive PSW was respected.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Eighty-eight (88) files were retained according to the criteria. There were 53 women (60.2%) and 35 men (39.8%) included; giving a sex ratio of 1.5: 1. The most represented age group was the one from 36 to 45 years with 31.8%, followed by that of 26 to 35 years (26.1%), 46 to 55 years (22.7%), 56 to 65 years (10.2%), and that of 18 to 25 years (8.0%). <xref ref-type="table" rid="table1">Table 1</xref> presents the above results.</p><p>The most diagnosed and recorded opportunistic infection was the Oral Candidiasis with 15.8% of cases; followed by non-specific Sexually Transmitted Infections (STI) with 14.3%, Malaria with 12.1%, Dermatitis with 8.1%, Tuberculosis (TBC) and Shingles with 6.2% respectively. <xref ref-type="table" rid="table2">Table 2</xref> presents all the diagnosed Opportunistic Infections in the population.</p></sec><sec id="s4"><title>4. Discussion</title><p>The objective of this study was to determine the prevalence of opportunistic infections among HIV infected Professional Sex Workers followed at the “Center IST Matonge” in Kinshasa, Democratic Republic of Congo.</p><p>Based on the inclusion criteria, out of 103 consulted, 88 files were selected. This is because there were unidentified and poorly kept records of PSWs in the center. This observation has been made by other studies in our environment [<xref ref-type="bibr" rid="scirp.117417-ref8">8</xref>].</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Frequencies of age by gender</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >AGE</th><th align="center" valign="middle"  colspan="2"  >MALE</th><th align="center" valign="middle"  colspan="2"  >FEMALE</th><th align="center" valign="middle"  colspan="2"  >TOTAL</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >18 - 25</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5.7</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >9.4</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >8.0</td></tr><tr><td align="center" valign="middle" >26 - 35</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >22.9</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >28.3</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >26.1</td></tr><tr><td align="center" valign="middle" >36 - 45</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >28.6</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >34.0</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >31.8</td></tr><tr><td align="center" valign="middle" >46 - 55</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >25.7</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >20.8</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >22.7</td></tr><tr><td align="center" valign="middle" >56 - 65</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >14.3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7.5</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >10.2</td></tr><tr><td align="center" valign="middle" >66 et plus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle"  colspan="2"  >35</td><td align="center" valign="middle"  colspan="2"  >53</td><td align="center" valign="middle"  colspan="2"  >88</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Opportunistic Infections diagnosed</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Opportunists Infection</th><th align="center" valign="middle"  colspan="2"  >MALE</th><th align="center" valign="middle"  colspan="2"  >FEMALE</th><th align="center" valign="middle"  colspan="2"  >TOTAL</th></tr></thead><tr><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Vaginal pruritus</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >8.7</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >5.5</td></tr><tr><td align="center" valign="middle" >Vaginitis</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >6.4</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >4.0</td></tr><tr><td align="center" valign="middle" >Pulmonary TBC</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Sexually Transmitted Infection</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >19.0</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >11.6</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >14.3</td></tr><tr><td align="center" valign="middle" >Oral candidiasis</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >16.0</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >15.6</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >15.8</td></tr><tr><td align="center" valign="middle" >Simple Herpes</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Dermatitis</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >9.0</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >7.5</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >8.1</td></tr><tr><td align="center" valign="middle" >Shingles</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >10.0</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >4.0</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >6.2</td></tr><tr><td align="center" valign="middle" >Malaria</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >13.0</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >11.6</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >12.1</td></tr><tr><td align="center" valign="middle" >Tooth decay</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Diarrhea</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.7</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Urinary tract infection</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.1</td></tr><tr><td align="center" valign="middle" >Genital mycosis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >4.0</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >3.7</td></tr><tr><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.3</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >Skin pruritus</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.3</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Bullous rash</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Typhoid fever</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Skin rash</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2.2</td></tr><tr><td align="center" valign="middle" >Genital rash</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Erythematous condyloma</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.7</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >Facial lymphadenopathy</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Filariasis</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Infected scabies</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >Intestinal Parasites</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td></tr><tr><td align="center" valign="middle" >Cortical mycosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Herpes Zosters’</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.2</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >TBC</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6.0</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >6.4</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >6.2</td></tr><tr><td align="center" valign="middle" >Rhinitis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.0</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >5.2</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >4.4</td></tr></tbody></table></table-wrap><p>The female sex is dominant compared to the male sex in this population, 53 women (60.2%) and 35 men (39.8%); thus giving a sex ratio of 1.5:1. This confirms the trends published in our community, which feminize HIV infection in the adult population [<xref ref-type="bibr" rid="scirp.117417-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref11">11</xref>]. This is justified by the fact that among adults, the country’s health policy requires women to be screened, especially during PreNatal Consultations (PNC), where screening is done systematically immediately after admission to the center. On the other hand, the PSW status is mostly and officially female in our mist.</p><p>The most represented age group was the one from 36 to 45 years with 31.8%, followed by that of 26 to 35 years (26.1%), 46 to 55 years (22.7%), 56 to 65 years (10.2%), and that of 18 to 25 years (8.0%). These results are correlated with other studies published in Kinshasa [<xref ref-type="bibr" rid="scirp.117417-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref9">9</xref>].</p><p>In this study, the Opportunistic Infections (OI) diagnosed in the population of HIV positive PSWs followed at the “IST Matonge” in Kinshasa were as followed: Oral Candidiasis with 15.8% of cases, followed by non-specific Sexually Transmitted Infections (STI) with 14.3%, Malaria with 12.1%, Dermatitis with 8.1%, Tuberculosis (TBC) and Shingles with 6.2% respectively, Vaginal pruritus with 5.5%, Rhinitis with 4.4%, Vaginitis with 4.0%, Genital mycosis with 3.7%, Pneumonia with 2.6%, Diarrhea, Skin pruritus and Skin rash with 2.2% respectively, Herpes zoster’ with 1.8%, Erythematous condyloma and Infected scabies with 1.5% respectively, Urinary tract infection with 1.1%, ended with Pulmonary TBC, Simple Herpes, Tooth decay, Bullous rash, Typhoid fever, Genital rash, Facial lymphadenopathy, Filariasis, Cortical mycosis with all less than 1%. These OI are commonly diagnosed in the HIV infected population in our mist [<xref ref-type="bibr" rid="scirp.117417-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.117417-ref11">11</xref>]. However, the prevalence is very different due to the specificities of the PSW population. Therefore, the OI among People Living with HIV (PLHIV) should not be correlated to those among the PSWs population.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Oral candidiasis (15.8%) was the most common Opportunistic Infection diagnosed among Professional Sex Workers followed at the “IST Matonge Center” in Kinshasa; followed by non-specific Sexually Transmitted Infections (14.3%), Malaria (12.1%), Dermatitis (8.1%), Tuberculosis (6.2%), and Shingles (6.2%). Therefore, the profile of OIs among PSWs living with HIV is different from that of general population.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="s7"><title>Cite this paper</title><p>Bongenya, B.I., Bulanda, B.I., Bukongo, R.N., Chuga, D., Botomuito, H.T., Kabasele, J.-Y.D. and Kamangu, E.N. (2022) Prevalence of Opportunist Infections among the Professionals Sex Workers and Their Customers Living with the VIH under ARV in Kinshasa. Open Access Library Journal, 9: e7927. https://doi.org/10.4236/oalib.1107927</p></sec><sec id="s8"><title>Abbreviation</title><p>AIDS Acquired ImmunoDeficiency Syndrome</p><p>DRC Democratic Republic of Congo</p><p>HIV Human Immunodeficiency Virus</p><p>OI Opportunistic Infection</p><p>PLHIV People Living with HIV</p><p>PNC PreNatal Consultation</p><p>PSW Professional Sex Worker</p><p>STI Sexually Transmitted Infection</p><p>WHO World Health Organization.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.117417-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">UNAIDS (2013) Global Summary of the AIDS Epidemics. UNAIDS.</mixed-citation></ref><ref id="scirp.117417-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Kamangu, N.E., Situakibanza, N.H., Mvumbi, L.G., Kakudji, I.L., Tshienda, T.D. and Mesia, K.G. (2012) Infection Opportunistes chez les personnes vivant avec le VIH suivies à l’H&amp;ocirc;pital Militaire de référence de Kinshasa (Camp Kokolo). Revue Congolaise de Sciences, 1, 66-76.</mixed-citation></ref><ref id="scirp.117417-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kamangu, N.E., Situakibanza, N.H., Mvumbi, L.G., Kakudj, I.L., Tshienda, T.D. and Mesia, K.G. (2012) Profiles of Opportunistic Infections in People Living with HIV Followed at the Military Hospital of Kinshasa Reference (Camp Kokolo), DRC. Retrovirology, 9, Article No. P146. https://doi.org/10.1186/1742-4690-9-S1-P146</mixed-citation></ref><ref id="scirp.117417-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">ONUSIDA (2009) Le VIH et le commerce du sexe—note d’orientation de l’ONUSIDA. ONUSIDA, Genève.</mixed-citation></ref><ref id="scirp.117417-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">ONUSIDA (2009) Le point sur l’épidémie du SIDA. ONUSIDA, Genève.</mixed-citation></ref><ref id="scirp.117417-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Nemoto, T., Iwamoto, M., Colby, D., Witts, S., Pishori, A., Le, M.N., et al. (2008) HIV-Related Risk Behaviors among Female Sex Workers in Ho Chi Minh City, Vietnam. AIDS Education and Prevention, 20, 435-453.  
https://doi.org/10.1521/aeap.2008.20.5.435</mixed-citation></ref><ref id="scirp.117417-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bongenia, I.B., Ilombo, L.L., Botomwito, T.H., Bulanda, I.B., Kamangu, N.E., Lusakibanza, M. and Mesia, K.G. (2014) Fréquence du suivi des paramètres biologiques des patients sous Anti Rétro Viraux à Kinshasa: Cas de l’H&amp;ocirc;pital Provinciale de Référence de Kinshasa. Journal des Recherches Biomédicales, 1, 1-6.</mixed-citation></ref><ref id="scirp.117417-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kamangu, E.N., Bongenya, B.I., Bulanda, B.I., Kalume, A.A., Mabanza, P.M. and Kalala, R.L. (2018) Molecular and Virological Profile of Professional Sex Workers (PSW) and Their Partners at the Beginning of ARV Treatment at IST Matonge in Kinshasa. Journal of HIV &amp; Retro Virus, 4, Article No. 10.  
https://doi.org/10.21767/2471-9676.100042</mixed-citation></ref><ref id="scirp.117417-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Situakibanza, H.N., Kapita, B.M., Mbendi, N., Odio, W., Mbula, M., Muvova, D., Mizerero, D. and Izzia, K. (1996) Etiologie de la fièvre au cours du SIDA: à propos de 64 cas. Panorama Médical, 1, 842-845.</mixed-citation></ref><ref id="scirp.117417-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Nyimi, M.L., Lepira, F.B., Sumaili, K.E., Ebengo, B.C., Nseka, M.N. and Longo, M.B. (2001) Insuffisance rénal aigue associée à l’infection par le VIH à Kinshasa: à propos de 24 observations. Louvain Médical, 120, 167-172.</mixed-citation></ref><ref id="scirp.117417-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kamangu, N.E., Mohindo, H., Wapa-Kamangu, W.C. and Situakibanza, N.H. (2015) Prevalence of Malaria Infection among People Living with HIV in Kinshasa. Open Access Library Journal, 2, e1077. https://doi.org/10.4236/oalib.1101077</mixed-citation></ref></ref-list></back></article>